The enhanced capabilities offered by panel-based sequencing approaches show considerable promise in public health microbiology. In Australia, we have found many areas where panel-based, culture-independent approaches have greatly strengthened our understanding of emerging and re-emerging infectious diseases. Many of these will be presented here, including respiratory viral detection and genotyping, as well as recovery of genomes from uncultivable organisms in patient and environmental samples. The data generated can be highly informative and actionable in a public health response.

Twist développe différents panels d’enrichissement ciblé dans le but d’optimiser les flux de travail de NGS. Afin de garantir la fiabilité des résultats de séquençage lors de l’utilisation de panels d’enrichissement ciblé, la quantification de la concentration peut être réalisée au niveau de la quantité du panel. Ces directives présentent le matériel requis et les étapes à suivre pour quantifier les panels d’enrichissement ciblé.

​​​​​​In the era of precision medicine, how can the power of AI be utilised to turn biological studies into the best possible targets? How can AI be applied to systems biology to bring the most effective targets to light? And how can we use these insights in the drug discovery process? In the webinar, 4 different experts will discuss the areas in which AI is bringing biological insights to the forefront, and Aaron Sato, Twist's CSO, will explain how Twist is enabling  the key players to write the Future of Biologics with Synthetic DNA and Machine Learning. Présenté par : Gary An, Prof. & Vice Chair of Surgical Research, University of Vermont Aaron K. Sato, CSO, Twist Bioscience Enkelejda Miho, Prof. of Digital Life Sciences, The FHNW University of Applied Sciences and Arts Northwestern Switzerland Philip Kim, Prof., The Donnelly Centre for Cellular and Biomolecular Research, University of Toronto